EKSO
Income statement / Annual
Last year (2024), Ekso Bionics Holdings, Inc.'s total revenue was $17.93 M,
a decrease of 1.94% from the previous year.
In 2024, Ekso Bionics Holdings, Inc.'s net income was -$11.33 M.
See Ekso Bionics Holdings, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$17.93 M |
$18.28 M |
$12.91 M |
$11.25 M |
$8.88 M |
$13.92 M |
$11.33 M |
$7.35 M |
$14.22 M |
$8.66 M |
| Cost of Revenue |
$8.41 M
|
$9.20 M
|
$6.70 M
|
$4.50 M
|
$3.81 M
|
$7.15 M
|
$7.02 M
|
$5.28 M
|
$11.27 M
|
$7.48 M
|
| Gross Profit |
$9.51 M
|
$9.08 M
|
$6.21 M
|
$6.75 M
|
$5.07 M
|
$6.76 M
|
$4.31 M
|
$2.07 M
|
$2.95 M
|
$1.18 M
|
| Gross Profit Ratio |
0.53
|
0.5
|
0.48
|
0.6
|
0.57
|
0.49
|
0.38
|
0.28
|
0.21
|
0.14
|
| Research and Development Expenses |
$3.87 M
|
$5.03 M
|
$3.63 M
|
$2.75 M
|
$2.47 M
|
$4.60 M
|
$5.85 M
|
$9.48 M
|
$8.88 M
|
$6.48 M
|
| General & Administrative Expenses |
$8.79 M
|
$10.69 M
|
$10.99 M
|
$10.52 M
|
$7.70 M
|
$7.41 M
|
$11.70 M
|
$10.72 M
|
$10.85 M
|
$7.00 M
|
| Selling & Marketing Expenses |
$7.31 M
|
$8.47 M
|
$7.16 M
|
$7.31 M
|
$7.75 M
|
$11.40 M
|
$13.83 M
|
$13.16 M
|
$11.00 M
|
$9.26 M
|
| Selling, General & Administrative Expenses |
$16.10 M
|
$19.17 M
|
$18.14 M
|
$17.83 M
|
$15.45 M
|
$18.81 M
|
$25.53 M
|
$23.87 M
|
$21.85 M
|
$16.26 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$296.00 K
|
-$166.00 K
|
-$45.00 K
|
| Operating Expenses |
$19.97 M
|
$24.19 M
|
$21.77 M
|
$20.58 M
|
$17.93 M
|
$23.40 M
|
$31.37 M
|
$33.35 M
|
$30.73 M
|
$22.74 M
|
| Cost And Expenses |
$28.39 M
|
$33.39 M
|
$28.47 M
|
$25.07 M
|
$21.74 M
|
$30.56 M
|
$38.40 M
|
$38.64 M
|
$42.00 M
|
$30.22 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$384.00 K
|
$0.00
|
$0.00
|
$12.00 K
|
$11.00 K
|
| Interest Expense |
$269.00 K
|
$302.00 K
|
$156.00 K
|
$113.00 K
|
$139.00 K
|
$384.00 K
|
$600.00 K
|
$648.00 K
|
$16.00 K
|
$13.00 K
|
| Depreciation & Amortization |
$1.61 M
|
$1.70 M
|
$887.00 K
|
$561.00 K
|
$620.00 K
|
$690.00 K
|
$1.50 M
|
$1.73 M
|
$1.86 M
|
$933.00 K
|
| EBITDA |
-$9.45 M |
-$13.20 M |
-$14.04 M |
-$9.09 M |
-$15.07 M |
-$11.06 M |
-$24.89 M |
-$26.74 M |
-$21.60 M |
-$18.64 M |
| EBITDA Ratio |
-0.53
|
-0.72
|
-1.09
|
-0.81
|
-1.7
|
-0.79
|
-2.2
|
-3.64
|
-1.52
|
-2.15
|
| Operating Income Ratio |
-0.58
|
-0.83
|
-1.2
|
-1.23
|
-1.45
|
-1.2
|
-2.39
|
-4.3
|
-1.94
|
-2.49
|
| Total Other Income/Expenses Net |
-$870.00 K
|
-$86.00 K
|
$476.00 K
|
$4.06 M
|
-$2.97 M
|
$4.51 M
|
$38.00 K
|
$2.49 M
|
$4.12 M
|
$1.97 M
|
| Income Before Tax |
-$11.33 M
|
-$15.20 M
|
-$15.08 M
|
-$9.76 M
|
-$15.83 M
|
-$12.13 M
|
-$26.99 M
|
-$29.12 M
|
-$23.47 M
|
-$19.59 M
|
| Income Before Tax Ratio |
-0.63
|
-0.83
|
-1.17
|
-0.87
|
-1.78
|
-0.87
|
-2.38
|
-3.96
|
-1.65
|
-2.26
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$11.33 M
|
-$15.20 M
|
-$15.08 M
|
-$9.76 M
|
-$15.83 M
|
-$12.13 M
|
-$26.99 M
|
-$29.12 M
|
-$23.47 M
|
-$19.59 M
|
| Net Income Ratio |
-0.63
|
-0.83
|
-1.17
|
-0.87
|
-1.78
|
-0.87
|
-2.38
|
-3.96
|
-1.65
|
-2.26
|
| EPS |
-0.56 |
-1.1 |
-1.16 |
-0.8 |
-2.21 |
-2.44 |
-6.61 |
-12.27 |
-19.42 |
-15.53 |
| EPS Diluted |
-0.56 |
-1.1 |
-1.16 |
-0.88 |
-2.21 |
-2.44 |
-6.61 |
-12.27 |
-18.9 |
-15.52 |
| Weighted Average Shares Out |
$20.16 M
|
$13.87 M
|
$12.96 M
|
$12.19 M
|
$7.16 M
|
$4.79 M
|
$4.08 M
|
$2.37 M
|
$1.21 M
|
$1.26 M
|
| Weighted Average Shares Out Diluted |
$20.16 M
|
$13.87 M
|
$12.96 M
|
$12.27 M
|
$7.16 M
|
$4.79 M
|
$4.08 M
|
$2.37 M
|
$1.24 M
|
$1.26 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
